2019
DOI: 10.1111/vox.12876
|View full text |Cite
|
Sign up to set email alerts
|

Global prevalence of human pegivirus‐1 in healthy volunteer blood donors: a systematic review and meta‐analysis

Abstract: Background and objectives The local prevalence of HPgV-1 has been reported from different countries worldwide, but the global prevalence of HPgV-1 remains unknown. The aim of this systematic review and meta-analysis was to gather data from the literature to estimate the prevalence of HPgV-1 in healthy volunteer blood donors in the world. Materials and methodsWe searched PubMed, EMBASE, Scopus and Google Scholar databases for records up to January 2019 and included studies reporting HPgV-1 virus prevalence amon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
26
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(26 citation statements)
references
References 94 publications
(349 reference statements)
0
26
0
Order By: Relevance
“…HPgV-1 (a Flaviviridae [35]) viremia occurs in 1-4% of blood donors in developed countries [36] and up to 30% of allo-HSCT recipients but has not been associated with clinical consequences [3,4]. Given the interaction of HPgV-1 with the immune system [37], the effect of persistent HPgV-1 viremia requires deeper investigation.…”
Section: Discussionmentioning
confidence: 99%
“…HPgV-1 (a Flaviviridae [35]) viremia occurs in 1-4% of blood donors in developed countries [36] and up to 30% of allo-HSCT recipients but has not been associated with clinical consequences [3,4]. Given the interaction of HPgV-1 with the immune system [37], the effect of persistent HPgV-1 viremia requires deeper investigation.…”
Section: Discussionmentioning
confidence: 99%
“…Pegivirus has no confirmed pathogenic effect [ 39 ]. It has both liver and immune cell tropism [ 40 ], and studies have shown that infection with HBV or HCV increase the risk of pegivirus infection [ 41 ]. Pegivirus is more prevalent in patients with liver transplant than partial hepatectomy patients, but pegivirus is not associated with any changes in clinical outcomes [ 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…Pegivirus is an RNA virus that belongs to the Flaviviridae family and commonly causes persistent infection (22,23). The global prevalence of pegivirus in healthy blood donors ranges from 1% to 9% among different regions (24), but in HIV-1infected populations, the prevalence is higher-up to more than 80% (25,26). Recent studies in China showed that the prevalences of pegivirus in intravenous drug users (IDUs) and MSM were ;30% and 18.3%, respectively (25,27), indicating a higher risk of transmission through blood.…”
Section: Discussionmentioning
confidence: 99%